J. Safra Sarasin Holding Ag Vera Therapeutics, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $6.19 Trillion
- Q3 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 55,317 shares of VERA stock, worth $1.57 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
55,317
Previous 29,567
87.09%
Holding current value
$1.57 Million
Previous $697 Million
130.77%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
194Shares Held
65.9MCall Options Held
128KPut Options Held
172K-
Avoro Capital Advisors LLC New York, NY6.21MShares$176 Million2.46% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.03MShares$114 Million9.86% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.67MShares$104 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.64MShares$103 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$94.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $766M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...